{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:17:26Z","timestamp":1767705446791,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Wright Foundation, Keck Medicine of University of Southern California, United States"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jdermsci.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T11:31:06Z","timestamp":1590751866000},"page":"30-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets"],"prefix":"10.1016","volume":"99","author":[{"given":"Marissa B.","family":"Lobl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dillon","family":"Clarey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Wysong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdermsci.2020.05.007_bib0005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Aug. (8)","key":"10.1016\/j.jdermsci.2020.05.007_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jdermsci.2020.05.007_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American joint committee on cancer, international union against cancer, and Brigham and women\u2019s hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jdermsci.2020.05.007_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.139.3.301","article-title":"Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study","volume":"139","author":"Martinez","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2020.05.007_bib0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1101\/gr.9.8.677","article-title":"dbSNP\u2014database for single nucleotide polymorphisms and other classes of minor genetic variation","volume":"9","author":"Sherry","year":"1999","journal-title":"Genome Res."},{"year":"2019","series-title":"COSMIC - Catalogue of Somatic Mutations in Cancer","author":"Cosmic","key":"10.1016\/j.jdermsci.2020.05.007_bib0030"},{"year":"2019","series-title":"ClinVar","key":"10.1016\/j.jdermsci.2020.05.007_bib0035"},{"key":"10.1016\/j.jdermsci.2020.05.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.jdermsci.2020.05.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: genomic visualizations in r","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jdermsci.2020.05.007_bib0050","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/bioinformatics\/btt395","article-title":"OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes","volume":"29","author":"Tamborero","year":"2013","journal-title":"Bioinformatics"},{"issue":"Aug.(7463)","key":"10.1016\/j.jdermsci.2020.05.007_bib0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"Nov. (22)","key":"10.1016\/j.jdermsci.2020.05.007_bib0060","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","article-title":"A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma","volume":"88","author":"Brash","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Oct. (43)","key":"10.1016\/j.jdermsci.2020.05.007_bib0065","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1073\/pnas.1114669108","article-title":"Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Apr. (7)","key":"10.1016\/j.jdermsci.2020.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/cncr.30459","article-title":"Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors","volume":"123","author":"Yilmaz","year":"2017","journal-title":"Cancer"},{"issue":"Mar. (6)","key":"10.1016\/j.jdermsci.2020.05.007_bib0075","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"Aug. (1)","key":"10.1016\/j.jdermsci.2020.05.007_bib0080","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12885-019-5990-9","article-title":"Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma","volume":"19","author":"Doma","year":"2019","journal-title":"BMC Cancer"},{"issue":"Sep. (9)","key":"10.1016\/j.jdermsci.2020.05.007_bib0085","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/1878-0261.12099","article-title":"Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights","volume":"11","author":"Dienstmann","year":"2017","journal-title":"Mol. Oncol."},{"issue":"Mar. (11)","key":"10.1016\/j.jdermsci.2020.05.007_bib0090","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"issue":"Nov. (5)","key":"10.1016\/j.jdermsci.2020.05.007_bib0095","doi-asserted-by":"crossref","first-page":"C675","DOI":"10.1152\/ajpcell.00291.2017","article-title":"Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt\/\u03b2-catenin signaling pathway","volume":"315","author":"Gao","year":"2018","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"Sep. (18)","key":"10.1016\/j.jdermsci.2020.05.007_bib0100","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1158\/0008-5472.CAN-18-0316","article-title":"Phase Ib results of the rational combination of Selumetinib and cyclosporin a in advanced solid tumors with an expansion cohort in metastatic colorectal cancer","volume":"78","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Res."},{"issue":"Mar. (3)","key":"10.1016\/j.jdermsci.2020.05.007_bib0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2003.06.002","article-title":"Signal transduction and oncogenesis by ErbB\/HER receptors","volume":"58","author":"Marmor","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Mar. (5)","key":"10.1016\/j.jdermsci.2020.05.007_bib0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res."},{"issue":"Oct. (10)","key":"10.1016\/j.jdermsci.2020.05.007_bib0115","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1172\/JCI75371","article-title":"Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis","volume":"124","author":"Okon","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"Jan. (2)","key":"10.1016\/j.jdermsci.2020.05.007_bib0120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of Co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"Apr. (14)","key":"10.1016\/j.jdermsci.2020.05.007_bib0125","doi-asserted-by":"crossref","first-page":"23831","DOI":"10.18632\/oncotarget.6379","article-title":"Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer","volume":"8","author":"P\u00e9cuchet","year":"2017","journal-title":"Oncotarget"},{"issue":"Dec. (24)","key":"10.1016\/j.jdermsci.2020.05.007_bib0130","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1158\/0008-5472.CAN-05-0716","article-title":"Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"issue":"37 Suppl (Sep)","key":"10.1016\/j.jdermsci.2020.05.007_bib0135","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities","volume":"4","author":"Yarden","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"Jan. (1)","key":"10.1016\/j.jdermsci.2020.05.007_bib0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/DSS.0000000000000799","article-title":"Cisplatin and cetuximab treatment for metastatic cutaneous squamous cell carcinoma: a systematic review","volume":"43","author":"Trodello","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"Feb. (2)","key":"10.1016\/j.jdermsci.2020.05.007_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/DSS.0000000000001583","article-title":"Response of cutaneous squamous cell carcinoma to treatment with cetuximab","volume":"45","author":"Berliner","year":"2019","journal-title":"Dermatol. Surg."},{"issue":"2","key":"10.1016\/j.jdermsci.2020.05.007_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056112","article-title":"Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab","volume":"8","author":"Ather","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2020.05.007_bib0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5732\/cjc.010.10542","article-title":"Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations","volume":"30","author":"Wykosky","year":"2011","journal-title":"Chin. J. Cancer"},{"year":"2019","series-title":"Clinicaltrials.gov. NIH National Library of Medicine","key":"10.1016\/j.jdermsci.2020.05.007_bib0160"},{"issue":"Feb. (3)","key":"10.1016\/j.jdermsci.2020.05.007_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)81279-9","article-title":"Cell adhesion: the molecular basis of tissue architecture and morphogenesis","volume":"84","author":"Gumbiner","year":"1996","journal-title":"Cell"},{"issue":"Jan. (2)","key":"10.1016\/j.jdermsci.2020.05.007_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/bjc.2015.347","article-title":"Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis","volume":"114","author":"Kim","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.jdermsci.2020.05.007_bib0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000450920","article-title":"Characterisation of prognosis and invasion of cutaneous squamous cell carcinoma by Podoplanin and E-Cadherin expression","volume":"232","author":"Hesse","year":"2016","journal-title":"Dermatology"},{"issue":"Sep. (14)","key":"10.1016\/j.jdermsci.2020.05.007_bib0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omto.2019.04.005","article-title":"Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers","volume":"27","author":"Song","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"issue":"Sep. (1)","key":"10.1016\/j.jdermsci.2020.05.007_bib0185","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jdermsci.2020.05.007_bib0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0286-z","article-title":"Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer","volume":"8","author":"Fox","year":"2016","journal-title":"Genome Med."},{"issue":"Aug. (8)","key":"10.1016\/j.jdermsci.2020.05.007_bib0195","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1055-9965.EPI-11-0150","article-title":"Tobacco smoking and cutaneous squamous cell carcinoma: a 16-year longitudinal population-based study","volume":"20","author":"McBride","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Jun. (6)","key":"10.1016\/j.jdermsci.2020.05.007_bib0200","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/DSS.0000000000001828","article-title":"A retrospective cohort study of cutaneous squamous cell carcinoma with lymph node metastasis: risk factors and clinical course","volume":"45","author":"Feinstein","year":"2019","journal-title":"Dermatol. Surg."},{"issue":"Dec. (6)","key":"10.1016\/j.jdermsci.2020.05.007_bib0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s13402-018-0404-6","article-title":"Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells","volume":"41","author":"Jeong","year":"2018","journal-title":"Cell Oncol. (Dordr)"},{"issue":"Feb. (2)","key":"10.1016\/j.jdermsci.2020.05.007_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/DSS.0000000000001755","article-title":"Cetuximab as a component of multimodality treatment of high-risk cutaneous squamous cell carcinoma: a retrospective analysis from a single tertiary academic medical center","volume":"45","author":"Trodello","year":"2019","journal-title":"Dermatol. Surg."},{"issue":"Oct. (10)","key":"10.1016\/j.jdermsci.2020.05.007_bib0215","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/annonc\/mdu368","article-title":"Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma","volume":"25","author":"Foote","year":"2014","journal-title":"Ann. Oncol."},{"issue":"Dec. (12)","key":"10.1016\/j.jdermsci.2020.05.007_bib0220","first-page":"1637","article-title":"Tipifarnib targets HRAS-mutant cancers","volume":"9","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.jdermsci.2020.05.007_bib0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1389450114666140106100909","article-title":"Therapeutic targeting of cancers with loss of PTEN function","volume":"15","author":"Dillon","year":"2014","journal-title":"Curr. Drug Targets"},{"issue":"March","key":"10.1016\/j.jdermsci.2020.05.007_bib0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2407-14-145","article-title":"Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer","volume":"14","author":"Agarwal","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181120301754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181120301754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:51:01Z","timestamp":1760331061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181120301754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0923181120301754"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2020.05.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"type":"print","value":"0923-1811"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}